Literature DB >> 16891330

Structural basis for induced-fit binding of Rho-kinase to the inhibitor Y-27632.

Hiroto Yamaguchi1, Yukiko Miwa, Miyuki Kasa, Ken Kitano, Mutsuki Amano, Kozo Kaibuchi, Toshio Hakoshima.   

Abstract

Rho-kinase is a main player in the regulation of cytoskeletal events and a promising drug target in the treatment of both vascular and neurological disorders. Here we report the crystal structure of the Rho-kinase catalytic domain in complex with the specific inhibitor Y-27632. Comparison with the structure of PKA bound to this inhibitor revealed a potential induced-fit binding mode that can be accommodated by the phosphate binding loop. This binding mode resembles to that observed in the Rho-kinase-fasudil complex. A structural database search indicated that a pocket underneath the phosphate-binding loop is present that favors binding to a small aromatic ring. Introduction of such a ring group might spawn a new modification scheme of pre-existing protein kinase inhibitors for improved binding capability.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16891330     DOI: 10.1093/jb/mvj172

Source DB:  PubMed          Journal:  J Biochem        ISSN: 0021-924X            Impact factor:   3.387


  21 in total

1.  Elaborate ligand-based modeling reveal new submicromolar Rho kinase inhibitors.

Authors:  Rand Shahin; Saja Alqtaishat; Mutasem O Taha
Journal:  J Comput Aided Mol Des       Date:  2011-12-14       Impact factor: 3.686

2.  Partial contribution of Rho-kinase inhibition to the bioactivity of Ganoderma lingzhi and its isolated compounds: insights on discovery of natural Rho-kinase inhibitors.

Authors:  Yhiya Amen; Qinchang Zhu; Hai-Bang Tran; Mohamed S Afifi; Ahmed F Halim; Ahmed Ashour; Kuniyoshi Shimizu
Journal:  J Nat Med       Date:  2017-01-10       Impact factor: 2.343

3.  In silico prediction of ROCK II inhibitors by different classification approaches.

Authors:  Chuipu Cai; Qihui Wu; Yunxia Luo; Huili Ma; Jiangang Shen; Yongbin Zhang; Lei Yang; Yunbo Chen; Zehuai Wen; Qi Wang
Journal:  Mol Divers       Date:  2017-08-02       Impact factor: 2.943

4.  Periodic propagating waves coordinate RhoGTPase network dynamics at the leading and trailing edges during cell migration.

Authors:  Alfonso Bolado-Carrancio; Oleksii S Rukhlenko; Elena Nikonova; Mikhail A Tsyganov; Anne Wheeler; Amaya Garcia-Munoz; Walter Kolch; Alex von Kriegsheim; Boris N Kholodenko
Journal:  Elife       Date:  2020-07-24       Impact factor: 8.140

5.  RSK2 Binding Models Delineate Key Features for Activity.

Authors:  Rick Gussio; Michael J Currens; Dominic A Scudiero; Jeffrey A Smith; Deborah A Lannigan; Robert H Shoemaker; Dan W Zaharevitz; Tam Luong Nguyen
Journal:  J Chem Pharm Res       Date:  2010

6.  PKCα-Mediated Signals Regulate the Motile Responses of Cochlear Outer Hair Cells.

Authors:  Channy Park; Federico Kalinec
Journal:  Biophys J       Date:  2015-05-05       Impact factor: 4.033

7.  Discovery of substituted 4-(pyrazol-4-yl)-phenylbenzodioxane-2-carboxamides as potent and highly selective Rho kinase (ROCK-II) inhibitors.

Authors:  Yangbo Feng; Yan Yin; Amiee Weiser; Evelyn Griffin; Michael D Cameron; Li Lin; Claudia Ruiz; Stephan C Schürer; Toshihiro Inoue; P Vasanth Rao; Thomas Schröter; Philip Lograsso
Journal:  J Med Chem       Date:  2008-10-04       Impact factor: 7.446

Review 8.  Rho-kinase/ROCK: A key regulator of the cytoskeleton and cell polarity.

Authors:  Mutsuki Amano; Masanori Nakayama; Kozo Kaibuchi
Journal:  Cytoskeleton (Hoboken)       Date:  2010-09

9.  Specific CLK inhibitors from a novel chemotype for regulation of alternative splicing.

Authors:  Oleg Fedorov; Kilian Huber; Andreas Eisenreich; Panagis Filippakopoulos; Oliver King; Alex N Bullock; Damian Szklarczyk; Lars J Jensen; Doriano Fabbro; Jörg Trappe; Ursula Rauch; Franz Bracher; Stefan Knapp
Journal:  Chem Biol       Date:  2011-01-28

10.  Structure of Shroom domain 2 reveals a three-segmented coiled-coil required for dimerization, Rock binding, and apical constriction.

Authors:  Swarna Mohan; Ryan Rizaldy; Debamitra Das; Robert J Bauer; Annie Heroux; Michael A Trakselis; Jeffrey D Hildebrand; Andrew P VanDemark
Journal:  Mol Biol Cell       Date:  2012-04-04       Impact factor: 4.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.